Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 934 ILS -0.64% Market Closed
Market Cap: ₪275.7m
Write Note Create Alert Ask AI

Epitomee Medical Ltd
Investor Relations

Epitomee Medical Ltd. develops and manufactures medical devices for obesity. The firm operates directly in the field of development, production and commercialization of medical platforms that are divided into two areas: the area of medical devices for weight loss and overweight, including the development and production of medical devices packed in capsules and ingested; the area of solutions for the introduction of drugs through ingestion that allows patients to take various medications that can be administered today only by injections. Both of the Company's solutions are intended for ingestion for patients for self-use, under a doctor's prescription and are under development.

Show more
Loading
EPIT
Tel Aviv 355
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Shimon Eckhouse Ph.D.
Co-Founder & Chairman of the Board
No Bio Available
Dr. Radan Hashimshony Ph.D.
CEO & General Secretary
No Bio Available
Ms. Maya Gabrieli
Vice President of Finance
No Bio Available
Mr. Gal Aharonowitz
Chief Operating Officer
No Bio Available
Dr. Yael Kidan
Vice President of Clinical Affairs
No Bio Available
Mr. Alon Heth
VP of Sales and Marketing
No Bio Available
Dr. Ruthie Amir M.D.
Chief Medical & Regulatory Officer
No Bio Available
Dr. Argil Cohen
CEO of R&D
No Bio Available

Contacts

Address
CAESAREA
Tarshish 19
Contacts
+972722505992
www.epitomeemedical.com
sparklesyt

See Also

Summary
EPIT intrinsic value, competitors valuation, and company profile.
DCF Valuation
EPIT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EPIT stock valuation using valuation multiples.
Wall Street Estimates
EPIT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EPIT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.